 | A1B8B | Name: | 6-(4-methylpiperazin-1-yl)-3-phenyl-4-(pyridin-4-yl)pyridazine | Formula: | C20 H21 N5 | SMILES: | CN1CCN(CC1)c1nnc(c2ccccc2)c(c1)c1ccncc1 | InChi: | InChI=1S/C20H21N5/c1-24-11-13-25(14-12-24)19-15-18(16-7-9-21-10-8-16)20(23-22-19)17-5-3-2-4-6-17/h2-10,15H,11-14H2,1H3 | Definition date: | 2025-04-09 | Last modified: | 2025-04-25 | Release date: | 2025-04-30 | Identifier: | 6-(4-methylpiperazin-1-yl)-3-phenyl-4-(pyridin-4-yl)pyridazine |
|
 | A1A0B | Name: | (6M)-6-{2,3-difluoro-5-[(methylamino)methyl]phenyl}-4-methylpyridin-2-amine | Formula: | C14 H15 F2 N3 | SMILES: | Cc1cc(nc(N)c1)c1cc(CNC)cc(F)c1F | InChi: | InChI=1S/C14H15F2N3/c1-8-3-12(19-13(17)4-8)10-5-9(7-18-2)6-11(15)14(10)16/h3-6,18H,7H2,1-2H3,(H2,17,19) | Definition date: | 2024-07-30 | Last modified: | 2025-04-25 | Release date: | 2025-04-30 | Identifier: | (6M)-6-{2,3-difluoro-5-[(methylamino)methyl]phenyl}-4-methylpyridin-2-amine |
|
 | A1A0E | Name: | (2M)-4-methyl-5'-[(methylamino)methyl][2,3'-bipyridin]-6-amine | Formula: | C13 H16 N4 | SMILES: | Cc1cc(nc(N)c1)c1cc(CNC)cnc1 | InChi: | InChI=1S/C13H16N4/c1-9-3-12(17-13(14)4-9)11-5-10(6-15-2)7-16-8-11/h3-5,7-8,15H,6H2,1-2H3,(H2,14,17) | Definition date: | 2024-07-30 | Last modified: | 2025-04-25 | Release date: | 2025-04-30 | Identifier: | (2M)-4-methyl-5'-[(methylamino)methyl][2,3'-bipyridin]-6-amine |
|
 | A1A0F | Name: | (6P)-4-methyl-6-{3-[(methylamino)methyl]-5-(trifluoromethyl)phenyl}pyridin-2-amine | Formula: | C15 H16 F3 N3 | SMILES: | Cc1cc(nc(N)c1)c1cc(CNC)cc(c1)C(F)(F)F | InChi: | InChI=1S/C15H16F3N3/c1-9-3-13(21-14(19)4-9)11-5-10(8-20-2)6-12(7-11)15(16,17)18/h3-7,20H,8H2,1-2H3,(H2,19,21) | Definition date: | 2024-07-30 | Last modified: | 2025-04-25 | Release date: | 2025-04-30 | Identifier: | (6P)-4-methyl-6-{3-[(methylamino)methyl]-5-(trifluoromethyl)phenyl}pyridin-2-amine |
|
 | A1A3F | Name: | (3P)-3-(6-amino-4-methylpyridin-2-yl)-5-[(methylamino)methyl]benzonitrile | Formula: | C15 H16 N4 | SMILES: | Cc1cc(nc(N)c1)c1cc(C#N)cc(CNC)c1 | InChi: | InChI=1S/C15H16N4/c1-10-3-14(19-15(17)4-10)13-6-11(8-16)5-12(7-13)9-18-2/h3-7,18H,9H2,1-2H3,(H2,17,19) | Definition date: | 2024-08-23 | Last modified: | 2025-04-25 | Release date: | 2025-04-30 | Identifier: | (3P)-3-(6-amino-4-methylpyridin-2-yl)-5-[(methylamino)methyl]benzonitrile |
|
 | A1A8T | Name: | 3-methyl-L-isovaline | Formula: | C6 H13 N O2 | SMILES: | CC(C)C(C)(N)C(=O)O | InChi: | InChI=1S/C6H13NO2/c1-4(2)6(3,7)5(8)9/h4H,7H2,1-3H3,(H,8,9)/t6-/m0/s1 | Definition date: | 2024-09-20 | Last modified: | 2025-04-25 | Release date: | 2025-04-30 | Identifier: | 3-methyl-L-isovaline |
|
 | PKX | Name: | 4-[(4-{[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dimethoxyquinazolin-2-yl]amino}piperidin-1-yl)methyl]benzamide | Formula: | C32 H34 N6 O4 | SMILES: | Cc1cc(C#N)cc(C)c1Oc1nc(nc2cc(OC)c(OC)cc21)NC1CCN(Cc2ccc(cc2)C(N)=O)CC1 | InChi: | InChI=1S/C32H34N6O4/c1-19-13-22(17-33)14-20(2)29(19)42-31-25-15-27(40-3)28(41-4)16-26(25)36-32(37-31)35-24-9-11-38(12-10-24)18-21-5-7-23(8-6-21)30(34)39/h5-8,13-16,24H,9-12,18H2,1-4H3,(H2,34,39)(H,35,36,37) | Definition date: | 2022-05-27 | Last modified: | 2025-04-25 | Release date: | 2025-04-30 | Identifier: | 4-[(4-{[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dimethoxyquinazolin-2-yl]amino}piperidin-1-yl)methyl]benzamide |
|
 | 5TI | Name: | 5-[3-(4-methoxyphenyl)prop-2-enylidene]-1,3-diazinane-2,4,6-trione | Formula: | C14 H12 N2 O4 | SMILES: | COc1ccc(C=CC=C2C(=O)NC(=O)NC2=O)cc1 | InChi: | InChI=1S/C14H12N2O4/c1-20-10-7-5-9(6-8-10)3-2-4-11-12(17)15-14(19)16-13(11)18/h2-8H,1H3,(H2,15,16,17,18,19) | Definition date: | 2021-08-24 | Last modified: | 2025-04-25 | Release date: | 2021-12-29 | Identifier: | 5-[3-(4-methoxyphenyl)prop-2-enylidene]-1,3-diazinane-2,4,6-trione |
|
 | B7M | Name: | (10E,12Z)-hexadeca-10,12-dienal | Formula: | C16 H28 O | SMILES: | O=CCCCCCCCCC=CC=C/CCC | InChi: | InChI=1S/C16H28O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h4-7,16H,2-3,8-15H2,1H3/b5-4-,7-6+ | Definition date: | 2009-03-12 | Last modified: | 2025-04-24 | Identifier: | (10E,12Z)-hexadeca-10,12-dienal |
|
 | HY1 | Name: | PHENYLACETALDEHYDE | Formula: | C8 H8 O | SMILES: | O=CCc1ccccc1 | InChi: | InChI=1S/C8H8O/c9-7-6-8-4-2-1-3-5-8/h1-5,7H,6H2 | Definition date: | 1999-08-26 | Last modified: | 2025-04-22 | Identifier: | phenylacetaldehyde |
|
 | A1BZA | Name: | 3-chloro-N-[(3M)-3-(1,3-oxazol-5-yl)-5-(trifluoromethyl)phenyl]benzamide | Formula: | C17 H10 Cl F3 N2 O2 | SMILES: | Clc1cccc(c1)C(=O)Nc1cc(cc(c1)c1cnco1)C(F)(F)F | InChi: | InChI=1S/C17H10ClF3N2O2/c18-13-3-1-2-10(5-13)16(24)23-14-6-11(15-8-22-9-25-15)4-12(7-14)17(19,20)21/h1-9H,(H,23,24) | Definition date: | 2025-03-06 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | 3-chloro-N-[(3M)-3-(1,3-oxazol-5-yl)-5-(trifluoromethyl)phenyl]benzamide |
|
 | A1BZB | Name: | 3-chloro-N-[(3M)-3-(1,3-oxazol-5-yl)phenyl]-N-(propan-2-yl)benzene-1-sulfonamide | Formula: | C18 H17 Cl N2 O3 S | SMILES: | Clc1cccc(c1)S(=O)(=O)N(c1cccc(c1)c1cnco1)C(C)C | InChi: | InChI=1S/C18H17ClN2O3S/c1-13(2)21(25(22,23)17-8-4-6-15(19)10-17)16-7-3-5-14(9-16)18-11-20-12-24-18/h3-13H,1-2H3 | Definition date: | 2025-03-06 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | 3-chloro-N-[(3M)-3-(1,3-oxazol-5-yl)phenyl]-N-(propan-2-yl)benzene-1-sulfonamide |
|
 | Y7Z | Name: | UCL1684 | Formula: | C34 H30 N4 | SMILES: | C1Nc2cc[n](Cc3cccc(C[n]4ccc(NCc5ccc1cc5)c6ccccc46)c3)c7ccccc27 | InChi: | InChI=1S/C34H30N4/c1-3-10-33-29(8-1)31-16-18-37(33)23-27-6-5-7-28(20-27)24-38-19-17-32(30-9-2-4-11-34(30)38)36-22-26-14-12-25(13-15-26)21-35-31/h1-20,35-36H,21-24H2 | Definition date: | 2023-11-28 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 |
|
 | A1D9A | Name: | (2~{S})-5-[bis(azanyl)methylideneamino]-2-[[5-[bis(4-chlorophenyl)methyl]-3-methyl-thiophen-2-yl]carbonylamino]pentanoic acid | Formula: | C25 H26 Cl2 N4 O3 S | SMILES: | Cc1cc(sc1C(=O)N[CH](CCCN=C(N)N)C(O)=O)C(c2ccc(Cl)cc2)c3ccc(Cl)cc3 | InChi: | InChI=1S/C25H26Cl2N4O3S/c1-14-13-20(21(15-4-8-17(26)9-5-15)16-6-10-18(27)11-7-16)35-22(14)23(32)31-19(24(33)34)3-2-12-30-25(28)29/h4-11,13,19,21H,2-3,12H2,1H3,(H,31,32)(H,33,34)(H4,28,29,30)/t19-/m0/s1 | Synonyms: | JR14a | Definition date: | 2024-06-17 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | (2~{S})-5-[bis(azanyl)methylideneamino]-2-[[5-[bis(4-chlorophenyl)methyl]-3-methyl-thiophen-2-yl]carbonylamino]pentanoic acid |
|
 | A1ECX | Name: | 2-[(~{E})-heptadec-10-enyl]-6-oxidanyl-benzoic acid | Formula: | C24 H38 O3 | SMILES: | CCCCCCC=CCCCCCCCCCc1cccc(O)c1C(O)=O | InChi: | InChI=1S/C24H38O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-21-19-17-20-22(25)23(21)24(26)27/h7-8,17,19-20,25H,2-6,9-16,18H2,1H3,(H,26,27) | Definition date: | 2024-10-03 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | 2-[(~{E})-heptadec-10-enyl]-6-oxidanyl-benzoic acid |
|
 | A1ENT | Name: | ~{N}-[4-[4-azanyl-7-methyl-5-[2-(3-methylimidazo[4,5-b]pyridin-6-yl)ethynyl]pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]prop-2-enamide | Formula: | C25 H20 N8 O | SMILES: | Cn1cnc2cc(cnc12)C#Cc3c(n(C)c4ncnc(N)c34)c5ccc(NC(=O)C=C)cc5 | InChi: | InChI=1S/C25H20N8O/c1-4-20(34)31-17-8-6-16(7-9-17)22-18(21-23(26)28-13-29-25(21)33(22)3)10-5-15-11-19-24(27-12-15)32(2)14-30-19/h4,6-9,11-14H,1H2,2-3H3,(H,31,34)(H2,26,28,29) | Definition date: | 2025-03-21 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | ~{N}-[4-[4-azanyl-7-methyl-5-[2-(3-methylimidazo[4,5-b]pyridin-6-yl)ethynyl]pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]prop-2-enamide |
|
 | A1IGZ | Name: | N-(2-(3-((4-(4-fluorophenyl)thiazol-2-yl)(methyl)amino)-6-(1-(methylsulfonyl)piperidin-4-yl)imidazo[1,2-b]pyridazin-2-yl)ethyl)-2-oxo-2,3-dihydrobenzo[d]oxazole-6-carboxamide | Formula: | C32 H31 F N8 O5 S2 | SMILES: | CN(c1scc(n1)c2ccc(F)cc2)c3n4nc(ccc4nc3CCNC(=O)c5ccc6NC(=O)Oc6c5)C7CCN(CC7)[S](C)(=O)=O | InChi: | InChI=1S/C32H31FN8O5S2/c1-39(31-36-26(18-47-31)19-3-6-22(33)7-4-19)30-25(11-14-34-29(42)21-5-8-24-27(17-21)46-32(43)37-24)35-28-10-9-23(38-41(28)30)20-12-15-40(16-13-20)48(2,44)45/h3-10,17-18,20H,11-16H2,1-2H3,(H,34,42)(H,37,43) | Synonyms: | N-[2-[3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-methyl-amino]-6-(1-methylsulfonylpiperidin-4-yl)imidazo[1,2-b]pyridazin-2-yl]ethyl]-2-oxidanylidene-3H-1,3-benzoxazole-6-carboxamide | Definition date: | 2024-07-02 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | ~{N}-[2-[3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-methyl-amino]-6-(1-methylsulfonylpiperidin-4-yl)imidazo[1,2-b]pyridazin-2-yl]ethyl]-2-oxidanylidene-3~{H}-1,3-benzoxazole-6-carboxamide |
|
 | A1AMA | Name: | (4S)-4-amino-6-(methanesulfonyl)hexanamide | Formula: | C7 H16 N2 O3 S | SMILES: | NC(CCC(N)=O)CCS(C)(=O)=O | InChi: | InChI=1S/C7H16N2O3S/c1-13(11,12)5-4-6(8)2-3-7(9)10/h6H,2-5,8H2,1H3,(H2,9,10)/t6-/m0/s1 | Definition date: | 2024-04-11 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | (4S)-4-amino-6-(methanesulfonyl)hexanamide |
|
 | A1I57 | Name: | (2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[(1~{S})-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide | Formula: | C27 H35 F N4 O4 S | SMILES: | C[CH](NC(=O)[CH]1C[CH](O)CN1C(=O)[CH](NC(=O)C2(F)CC2)C(C)(C)C)c3ccc(cc3)c4scnc4C | InChi: | InChI=1S/C27H35FN4O4S/c1-15(17-6-8-18(9-7-17)21-16(2)29-14-37-21)30-23(34)20-12-19(33)13-32(20)24(35)22(26(3,4)5)31-25(36)27(28)10-11-27/h6-9,14-15,19-20,22,33H,10-13H2,1-5H3,(H,30,34)(H,31,36)/t15-,19+,20-,22+/m0/s1 | Definition date: | 2025-03-17 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | (2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[(1~{S})-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide |
|
 | A1I58 | Name: | (2~{S},4~{R})-1-[(2~{S})-1-(1-fluoranylcyclopropyl)carbonylpiperidin-2-yl]carbonyl-~{N}-[(1~{S})-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide | Formula: | C27 H33 F N4 O4 S | SMILES: | C[CH](NC(=O)[CH]1C[CH](O)CN1C(=O)[CH]2CCCCN2C(=O)C3(F)CC3)c4ccc(cc4)c5scnc5C | InChi: | InChI=1S/C27H33FN4O4S/c1-16(18-6-8-19(9-7-18)23-17(2)29-15-37-23)30-24(34)22-13-20(33)14-32(22)25(35)21-5-3-4-12-31(21)26(36)27(28)10-11-27/h6-9,15-16,20-22,33H,3-5,10-14H2,1-2H3,(H,30,34)/t16-,20+,21-,22-/m0/s1 | Definition date: | 2025-03-17 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | (2~{S},4~{R})-1-[(2~{S})-1-(1-fluoranylcyclopropyl)carbonylpiperidin-2-yl]carbonyl-~{N}-[(1~{S})-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide |
|
 | A1IER | Name: | (~{R})-(7-chloranylimidazo[1,5-a]pyridin-5-yl)-(1-phenyl-1,2,3-triazol-4-yl)methanol | Formula: | C16 H12 Cl N5 O | SMILES: | O[CH](c1cn(nn1)c2ccccc2)c3cc(Cl)cc4cncn34 | InChi: | InChI=1S/C16H12ClN5O/c17-11-6-13-8-18-10-21(13)15(7-11)16(23)14-9-22(20-19-14)12-4-2-1-3-5-12/h1-10,16,23H | Definition date: | 2024-06-14 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | (~{R})-(7-chloranylimidazo[1,5-a]pyridin-5-yl)-(1-phenyl-1,2,3-triazol-4-yl)methanol |
|
 | A1L1E | Name: | NE52-QQ57 | Formula: | C24 H28 N6 O | SMILES: | CCc1nn2c(C)cc(C)nc2c1Cc3ccc(cc3)c4oc(nn4)C5CCNCC5 | InChi: | InChI=1S/C24H28N6O/c1-4-21-20(22-26-15(2)13-16(3)30(22)29-21)14-17-5-7-18(8-6-17)23-27-28-24(31-23)19-9-11-25-12-10-19/h5-8,13,19,25H,4,9-12,14H2,1-3H3 | Synonyms: | 2-[4-[(2-ethyl-5,7-dimethyl-pyrazolo[1,5-a]pyrimidin-3-yl)methyl]phenyl]-5-piperidin-4-yl-1,3,4-oxadiazole | Definition date: | 2024-05-01 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | 2-[4-[(2-ethyl-5,7-dimethyl-pyrazolo[1,5-a]pyrimidin-3-yl)methyl]phenyl]-5-piperidin-4-yl-1,3,4-oxadiazole |
|
 | A1L6M | Name: | 3-[5-[(~{Z})-(3-ethyl-4-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-2-[(~{Z})-[4-(hydroxymethyl)-3-(3-hydroxy-3-oxopropyl)-5-[(~{Z})-[3-methyl-5-oxidanylidene-4-[(1~{S},4~{E},8~{Z})-5,9,13-trimethyl-1-oxidanyl-tetradeca-4,8,12-trienyl]pyrrol-2-ylidene]methyl]pyrrol-2-ylidene]methyl]-4-methyl-1~{H}-pyrrol-3-yl]propanoic acid | Formula: | C48 H62 N4 O8 | SMILES: | CCC1=C(C)C(=O)NC1=Cc2[nH]c(C=C3N=C(C=C4NC(=O)C(=C4C)[CH](O)CCC=C(C)CCC=C(C)CCC=C(C)C)C(=C3CCC(O)=O)CO)c(CCC(O)=O)c2C | InChi: | InChI=1S/C48H62N4O8/c1-9-33-31(7)47(59)52-39(33)23-37-30(6)34(19-21-44(55)56)40(49-37)25-41-35(20-22-45(57)58)36(26-53)42(50-41)24-38-32(8)46(48(60)51-38)43(54)18-12-17-29(5)16-11-15-28(4)14-10-13-27(2)3/h13,15,17,23-25,43,49,53-54H,9-12,14,16,18-22,26H2,1-8H3,(H,51,60)(H,52,59)(H,55,56)(H,57,58)/b28-15-,29-17+,38-24-,39-23-,41-25-/t43-/m0/s1 | Definition date: | 2024-12-04 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | 3-[5-[(~{Z})-(3-ethyl-4-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-2-[(~{Z})-[4-(hydroxymethyl)-3-(3-hydroxy-3-oxopropyl)-5-[(~{Z})-[3-methyl-5-oxidanylidene-4-[(1~{S},4~{E},8~{Z})-5,9,13-trimethyl-1-oxidanyl-tetradeca-4,8,12-trienyl]pyrrol-2-ylidene]methyl]pyrrol-2-ylidene]methyl]-4-methyl-1~{H}-pyrrol-3-yl]propanoic acid |
|
 | A1AV9 | Name: | Targocil-II | Formula: | C26 H22 Cl N O6 | SMILES: | O=C(O)C1CCCN1C(=O)CC1=C(C)c2cc3c(occ3c3ccc(Cl)cc3)c(C)c2OC1=O | InChi: | InChI=1S/C26H22ClNO6/c1-13-17-10-19-20(15-5-7-16(27)8-6-15)12-33-23(19)14(2)24(17)34-26(32)18(13)11-22(29)28-9-3-4-21(28)25(30)31/h5-8,10,12,21H,3-4,9,11H2,1-2H3,(H,30,31)/t21-/m1/s1 | Synonyms: | 1-{[3-(4-chlorophenyl)-5,9-dimethyl-7-oxo-7H-furo[3,2-g][1]benzopyran-6-yl]acetyl}-D-proline | Definition date: | 2024-06-28 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | 1-{[3-(4-chlorophenyl)-5,9-dimethyl-7-oxo-7H-furo[3,2-g][1]benzopyran-6-yl]acetyl}-D-proline |
|
 | A1AZU | Name: | 4-[(diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-[(3R)-pyrrolidin-3-yl]benzamide | Formula: | C25 H35 N3 O2 | SMILES: | CCN(CC)Cc1ccc(cc1)C(=O)N(CCc1ccccc1OC)C1CCNC1 | InChi: | InChI=1S/C25H35N3O2/c1-4-27(5-2)19-20-10-12-22(13-11-20)25(29)28(23-14-16-26-18-23)17-15-21-8-6-7-9-24(21)30-3/h6-13,23,26H,4-5,14-19H2,1-3H3/t23-/m1/s1 | Definition date: | 2024-07-24 | Last modified: | 2025-04-18 | Release date: | 2025-04-23 | Identifier: | 4-[(diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-[(3R)-pyrrolidin-3-yl]benzamide |
|